Security key
28657F103
Elicio Therapeutics, Inc. - Common Stock, par value $0.01 per share (ELTX)
CUSIP: 28657F103
Q2 2023 13F Holders as of 30 Jun 2023
- Security type / class
- Equity / Common Stock, par value $0.01 per share
- Total 13F shares
- 285,765
- Total 13F value
- $2,714,943
- Share change
- +285,765
- SEC-reported price per share
- $9.50
- Number of holders
- 15
- Value change
- +$2,714,943
- Number of buys
- 15
- Shares outstanding
- 23,096,590
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2023
Institutions
15
Top holders
10
ELTX full security history
Ownership snapshot
Full 13F holder table
Elicio Therapeutics, Inc. SEC filings
Elicio Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of ELTX - Elicio Therapeutics, Inc. - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
EISA-ABC LLC
Disclosed value leader
EISA-ABC LLC
Comparable rows
0/7
Latest evidence
01 Jul 2022
3/4/5
Highest disclosed value: $15,925,082
7 rows are not safely comparable across share classes.
Showing 1-6 of 7 holder rows.
Quick read
EISA-ABC LLC has the largest disclosed position value at $15.93M.
0 of 7 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens EISA-ABC LLC's linked filing trail.
Disclosed position value
Top 4
EISA-ABC LLC
$15.93M
Itzhak Goldberg
$9.81M
Gilbert S. Omenn
$87.2K
Victor F. Ganzi
$87.2K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 7 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| EISA-ABC LLC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$15,925,082
2,740,978 shares
|
— | 31 Aug 2021 |
| Itzhak Goldberg |
3/4/5
Director
|
—
class O/S missing
|
$9,807,199
1,687,986 shares
|
— | 01 Jul 2022 |
| Gilbert S. Omenn |
3/4/5
Director
|
—
class O/S missing
|
$87,150
15,000 shares
|
— | 09 Jun 2022 |
| Victor F. Ganzi |
3/4/5
Director
|
—
class O/S missing
|
$87,150
15,000 shares
|
— | 09 Jun 2022 |
| Jennifer J. Rhodes |
3/4/5
Executive Vice President, Chief Business Officer, General Counsel, Chief Compliance Officer and Secretary
|
—
class O/S missing
|
—
275,000 shares
|
— | 02 Mar 2022 |
| John F. Neylan |
3/4/5
Executive Vice President, Chief Medical Officer and Head of Research
|
—
class O/S missing
|
—
275,000 shares
|
— | 02 Mar 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
15
Shares
285,765
Rows available
15
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
0
Q2 2023 holders
15
Holder diff
15
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q2 2023 value | Value change | Value Chg % |
|---|